Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 6 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $65K 450 sh |
| Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Litinsky James H.Director, Chairman and CEO | Grant or award | A | — 38.2K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 6 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $65K 450 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 5 | Truong KristinaChief Accounting Officer | Tax withholding | F | $2,233 282 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 5 | Majalya Sidney A.SVP, CLO and Secretary | Open-market sale · 10b5-1 plan | SELL | $48K 775 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS | Grant or award | A | $1,415 60 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Giordano Christopher ThomasDirector, CEO | Grant or award | A | — 450.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Brown Andrew William FraserDirector | Grant or award | A | — 1,076 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 5 | Hartz Joseph L.President of Subsidiary | Option exercise | M | — 4,390 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 5 | Yake AliceDirector | Grant or award | A | — 1,200 sh | Jan 13, 2026 traded Jan 10, 2026 |
| 5 | Taub RebeccaDirector | Option exercise · 10b5-1 plan | M | $291K 18.4K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Rich StuartDirector, Chief Medical Officer | Grant or award | A | — 250.0K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 5 | Bell Hans G.President of Subsidiary | Option exercise | M | — 3,310 sh | Jan 13, 2026 traded Jan 11, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $703K 16.8K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $303K 6,841 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | $1.15M 7,875 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Lee JanetGC & Corporate Secretary | Open-market sale · 10b5-1 plan | SELL | $133K 250 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | $1.72M 14.6K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $392K 9,059 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 4 | Dines DanielDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $773K 45.0K sh | Jan 13, 2026 traded Jan 13, 2026 |
| 4 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $96K 2,265 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 3 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | — 7,875 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Farquhar ScottDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $25K 169 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Benkowitz MichaelPRESIDENT AND COO | Option exercise · 10b5-1 plan | M | — 14.6K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 3 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 2,170 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 3 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $25K 170 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 1 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $173K 4,100 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 1 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $57K 2,500 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 1 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $57K 2,500 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 1 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $82K 2,010 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 0 | Ahn KennethPresident, Hagerty Marketplace | Derivative conversion · 10b5-1 plan | C | — 1,350 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 0 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $29K 685 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 0 | Rodman David MalcomChief Medical Officer | Option exercise · 10b5-1 plan | M | — 6,348 sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Taub RebeccaDirector | Option exercise · 10b5-1 plan | M | — 240 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 0 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $22K 510 sh | Jan 13, 2026 traded Jan 13, 2026 |
| 0 | Ahn KennethPresident, Hagerty Marketplace | Derivative conversion · 10b5-1 plan | C | — 50.0K sh | Jan 13, 2026 traded Jan 12, 2026 |
| 0 | Taub RebeccaDirector | Option exercise · 10b5-1 plan | M | — 18.4K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 0 | Friedman Paul ADirector | Option exercise · 10b5-1 plan | M | — 24.5K sh | Jan 13, 2026 traded Jan 9, 2026 |
| 0 | Taub RebeccaDirector | Option exercise · 10b5-1 plan | M | $3,792 240 sh | Jan 13, 2026 traded Jan 9, 2026 |
| 0 | Friedman Paul ADirector | Option exercise · 10b5-1 plan | M | — 280 sh | Jan 13, 2026 traded Jan 9, 2026 |